Autopsy report · NCT00486798

FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“study was not ethically acceptable to continue and therefore it was finally stopped”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 3 months before it stopped.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 3
Sponsor: AstraZeneca
Sponsor type: Industry
Conditions: Psychotic Disorders; Schizophrenia; Bipolar Disorder
Interventions: Quetiapine; Rating Scales; Self Assessment Form; Blood and urine samples; Sleeping pattern
Sites: 13
Countries: Sweden

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.